🇺🇸 Mumps vaccine in United States
61 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 61
Most-reported reactions
- Pyrexia — 7 reports (11.48%)
- Dehydration — 6 reports (9.84%)
- Drug Hypersensitivity — 6 reports (9.84%)
- Drug Intolerance — 6 reports (9.84%)
- Dyspnoea — 6 reports (9.84%)
- Febrile Neutropenia — 6 reports (9.84%)
- Gastrointestinal Disorder — 6 reports (9.84%)
- Injury — 6 reports (9.84%)
- Pneumonia — 6 reports (9.84%)
- Respiratory Arrest — 6 reports (9.84%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is Mumps vaccine approved in United States?
Mumps vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Mumps vaccine in United States?
Sinovac (Dalian) Vaccine Technology Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.